A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease | MicrobiomeTrials
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-12-23Est. Completion: 2027-11-24
Enrollment target: 162 participants
Locations
Alabama Clinical Therapeutics, Birmingham, Alabama, United States
Solaris Research Institute, San Diego, California, United States
Source Healthcare, Santa Monica, California, United States
International Spine, Pain and Performance Center, Washington D.C., District of Columbia, United States
Conquest Research, Orlando, Florida, United States
Vantage Clinical Trials, St. Petersburg, Florida, United States
Vantage Clinical Trials, Tampa, Florida, United States
Injury Care Family Care Research, Boise, Idaho, United States
Axis Spine Center, Post Falls, Idaho, United States
Indiana Spine Group, Carmel, Indiana, United States
The Orthopedic Center of St. Louis, St Louis, Missouri, United States
Wake Research, Wilmington, North Carolina, United States
Carolinas Pain Institute/ Center For Clinical Research, Winston-Salem, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
Pacific Sports and Spine, Eugene, Oregon, United States
Semmes Murphey Neurological Clinic, Memphis, Tennessee, United States
Other microbiome trials you might be interested in